ameliaeve030

Community Stats

• Group User
• Active Posts 0
• Profile Views 946
• Time Online8m 41s
• Member Title Newbie
• Age 25 years old
• Birthday November 16, 1999
• Gender
  Male
• Location
  USA
• Interests
  Pharmacology: Pharmacodynamics: Mechanism of action: Ibrutinib is a potent, small-molecule inhibitor of Bruton's tyrosine kinase (BTK). Ibrutinib forms a covalent bond with a cysteine residue (Cys-481) in the BTK active site, leading to sustained inhibition of BTK enzymatic activity. BTK, a member of the Tec kinase family, is an important signalling molecule of the B-cell antigen receptor (BCR) and cytokine receptor pathways. The BCR pathway is implicated in the pathogenesis of several B-cell malignancies, including MCL, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and CLL. BTK's pivotal role in signalling through the B-cell surface receptors results in activation of pathways necessary for B-cell trafficking, chemotaxis and adhesion. Preclinical studies have shown that ibrutinib effectively inhibits malignant B-cell proliferation and survival in vivo as well as cell migration and substrate adhesion in vitro.

Contact Information

• Website URL   https://www.heptopic.com/generic/ibrutinib-cost-usa

Game Activity